Kindred Biosciences, Inc. – NASDAQ:KIN
Kindred Biosciences stock price today
$9.25
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 19 hours
Kindred Biosciences stock price monthly change
+1.43%
month
Kindred Biosciences stock price quarterly change
+91.51%
quarter
Kindred Biosciences stock price yearly change
+120.76%
year
Kindred Biosciences key metrics
Market Cap | N/A |
Enterprise value | 395.32M |
P/E | -9.08 |
EV/Sales | 49.87 |
EV/EBITDA | -11.15 |
Price/Sales | 52.84 |
Price/Book | 5.25 |
PEG ratio | -0.13 |
EPS | -1.06 |
Revenue | 7.92M |
EBITDA | -35.44M |
Income | -43.62M |
Revenue Q/Q | -91.06% |
Revenue Y/Y | -81.42% |
Profit margin | -529.26% |
Oper. margin | -497.34% |
Gross margin | 75.84% |
EBIT margin | -497.34% |
EBITDA margin | -447.17% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeKindred Biosciences stock price history
Kindred Biosciences stock forecast
Kindred Biosciences financial statements
| Sep 2020 | 1.04M | -12.73M | -1221.19% |
|---|---|---|---|
| Dec 2020 | 951K | -11.43M | -1202.31% |
| Mar 2021 | 2.39M | -9.74M | -406.68% |
| Jun 2021 | 3.53M | -9.71M | -274.58% |
| 2021-03-16 | -0.29 | -0.28 |
|---|---|---|
| 2021-05-11 | -0.24 | -0.24 |
| 2021-08-05 | -0.12 | -0.2 |
| Sep 2020 | 104539000 | 28.00M | 26.79% |
|---|---|---|---|
| Dec 2020 | 95814000 | 28.33M | 29.57% |
| Mar 2021 | 109979000 | 26.19M | 23.82% |
| Jun 2021 | 108872000 | 29.10M | 26.73% |
| Sep 2020 | -10.42M | 307K | -170K |
|---|---|---|---|
| Dec 2020 | -6.56M | 1.27M | 296K |
| Mar 2021 | -9.40M | -2.48M | 13.17M |
| Jun 2021 | -2.64M | 22.65M | 13.79M |
Kindred Biosciences alternative data
| Aug 2023 | 63 |
|---|---|
| Sep 2023 | 63 |
| Oct 2023 | 63 |
| Nov 2023 | 63 |
| Dec 2023 | 63 |
| Jan 2024 | 63 |
| Feb 2024 | 63 |
| Apr 2024 | 63 |
| May 2024 | 63 |
| Jun 2024 | 63 |
| Jul 2024 | 63 |
Kindred Biosciences other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2020 | 0 | 515 |
| Oct 2020 | 0 | 12508 |
| Jan 2021 | 0 | 265864 |
| Feb 2021 | 0 | 4627 |
| Mar 2021 | 0 | 8396 |
| Jun 2021 | 0 | 454983 |
| Jul 2021 | 0 | 40000 |
| Aug 2021 | 45508938 | 40000 |
| Patent |
|---|
Application Filling date: 4 Mar 2022 Issue date: 16 Jun 2022 |
Application Filling date: 20 Mar 2020 Issue date: 2 Jun 2022 |
Application Filling date: 26 Dec 2019 Issue date: 3 Mar 2022 |
Application Filling date: 14 Sep 2019 Issue date: 17 Feb 2022 |
Application Filling date: 12 Dec 2019 Issue date: 27 Jan 2022 |
Application Filling date: 24 Oct 2019 Issue date: 23 Dec 2021 |
Application Filling date: 18 Oct 2019 Issue date: 16 Dec 2021 |
Application Filling date: 30 Sep 2020 Issue date: 3 Jun 2021 |
Application Filling date: 18 Apr 2019 Issue date: 4 Mar 2021 |
Application Filling date: 5 Jun 2018 Issue date: 4 Feb 2021 |
| Quarter | Transcript |
|---|---|
| Q1 2021 11 May 2021 | Q1 2021 Earnings Call Transcript |
| Q4 2020 16 Mar 2021 | Q4 2020 Earnings Call Transcript |
| Q2 2020 8 Aug 2020 | Q2 2020 Earnings Call Transcript |
| Q1 2020 10 May 2020 | Q1 2020 Earnings Call Transcript |
-
What's the price of Kindred Biosciences stock today?
One share of Kindred Biosciences stock can currently be purchased for approximately $9.25.
-
When is Kindred Biosciences's next earnings date?
Unfortunately, Kindred Biosciences's (KIN) next earnings date is currently unknown.
-
Does Kindred Biosciences pay dividends?
No, Kindred Biosciences does not pay dividends.
-
What is Kindred Biosciences's stock symbol?
Kindred Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "KIN".
-
What is Kindred Biosciences's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Kindred Biosciences?
Shares of Kindred Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Kindred Biosciences have?
As Jul 2024, Kindred Biosciences employs 63 workers.
-
When Kindred Biosciences went public?
Kindred Biosciences, Inc. is publicly traded company for more then 11 years since IPO on 12 Dec 2013.
-
What is Kindred Biosciences's official website?
The official website for Kindred Biosciences is kindredbio.com.
-
Where are Kindred Biosciences's headquarters?
Kindred Biosciences is headquartered at 1555 Bayshore Hwy Ste 200, Burlingame, CALIFORNIA.
-
How can i contact Kindred Biosciences?
Kindred Biosciences's mailing address is 1555 Bayshore Hwy Ste 200, Burlingame, CALIFORNIA and company can be reached via phone at +1 650 701 7901.
Kindred Biosciences company profile:
Kindred Biosciences, Inc.
kindredbio.comExchange:
NASDAQ
Full time employees:
63
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.
1555 Bayshore Hwy Ste 200
Burlingame, CALIFORNIA 94010
Burlingame, CALIFORNIA 94010
CIK: 0001561743
ISIN: US4945771099
CUSIP: 494577109
